Premia CSI Caixin China New Economy ETF (03173)
- 10.250
- -0.050-0.49%
Premia CSI Caixin China New Economy ETF (03173) News
Optoelectronics Expo Opens Today; New Developments in CPO/NPO May Serve as Major Catalyst for the Sector
1. The 2026 China International Optoelectronic Exposition (CIOE) will be held at the Shenzhen World Exhibition & Convention Center from September 9 to 11. 2. According to research by Guolian Minsheng Securities, progress in the industrialization of new architectures such as NPO, CPO, and XPO is expected to be a key highlight of this year's exhibition.
The energy-saving business behind the surge in AI power consumption has attracted investments from CATL and Aramco.
① From Tencent’s data centers to CATL’s factories, Deep Intelligence Control is targeting the same issue: how to leverage AI to further unlock energy efficiency potential across entire systems after devices have already achieved automated control. ② It is evident that the expansion of computing power is forging a tighter bidirectional relationship between AI and energy: AI development demands more electricity, while also making the operational efficiency of energy systems increasingly critical.
[Market Data Watch] Institutional activity declines significantly as multiple capital streams coordinate to accumulate shares in Yingxin Development
1. Institutional activity on the "Longhu Bang" (top gainers and losers list) has declined significantly, with a substantial decrease in both the number of stocks purchased and the net buying volume. 2. Yingxin Development, a concept stock related to memory chips, hit its daily upper limit. It saw purchases of RMB 134 million from the Wuhan Ziyang East Road Branch of Guotai Haitong Securities, RMB 133 million from the Chengdu North First Ring Road Branch of Guotai Haitong Securities, and RMB 76 million from the Xi'an West Street Branch of Kaiyuan Securities.
Li Auto accelerates in-house R&D as automakers collectively introduce secondary suppliers; is the power battery industry on the verge of a major shift?
Li Auto invested RMB 2.65 billion in Sunwoda Power, accelerating the switch to self-developed batteries across its entire lineup, directly targeting a reduction in reliance on CATL. Harmony Intelligent Mobility Alliance (HIMA), Xiaomi, XPeng, and others are also intensifying the introduction of secondary and multiple suppliers, restructuring battery pricing and supply chain influence; however, CATL’s market share remains above 50%, and its dominant position has yet to be shaken. The power dynamics within the power battery industry are being quietly reshaped. Li Auto’s RMB 2.65 billion investment in Sunwoda Power, coupled with the announcement of switching its entire vehicle lineup to self-developed batteries, moves the "de-CATLization" strategy from slogan to substantive action. On September 8, CATL’s stock price fell sharply, with A-share $CATL(30075
No specific orders have been finalized in the cooperation with CATL! 20CM PCB concept stock issues announcement on unusual trading activity | Post-market announcements roundup
Xinhua Media: Planning to issue shares to acquire controlling stake in Jiemian Cailianshe and suspends trading
Insurance capital conducts intensive due diligence! Frequent visits to AMEC and Luxshare Precision. Institutional investors: Reassessing investment opportunities in the dividend sector with a more balanced focus.
① Industry insiders say that recent research efforts have largely focused on earnings reports. At present, the technology sector is experiencing significant volatility, and market capital is
Day 2 of the 2026 National Reimbursement Drug List (NRDL) negotiations: Two CAR-T therapies vie for basic medical insurance coverage as executives from multiple companies maintain on-site presence.
1. As the national reimbursement drug negotiations entered their second day, several innovative drugs and products with high clinical value were brought to the negotiating table; 2. In line with past practice, innovative drugs that are relatively more difficult to negotiate, such as anti-cancer medications and treatments for rare diseases, tend to be scheduled more intensively in the subsequent days. The lineup of participating companies suggests that this arrangement has largely been maintained.
On-the-ground report from Day 2 of the 2026 NRDL negotiations: Blockbuster oncology drugs, including CAR-T therapies and the world’s first bispecific antibody-drug conjugate (ADC), made their debut, while products covered by commercial insurance sought to
① On the second day of national reimbursement negotiations, the focus shifted to innovative oncology drugs, with nearly 20 companies—including Hengrui Medicine, Eli Lilly and Co, Novartis, and Innovent Biologics—participating in the morning session; ② In the afternoon, multinational pharmaceutical firms took center stage, with Merck & Co, Roche, and Johnson & Johnson successively entering negotiations as several blockbuster innovative drugs were brought to the table; ③ Companies such as Heyuan Biopharma and JW Therapeutics, which emerged as new entrants in commercial health insurance formularies last year, are once again attempting to break into the basic medical insurance scheme, marking the transition of dual-formulary alignment into the practical implementation phase.
Day One of the 2026 National Reimbursement Drug List Negotiations: Representatives from Multiple Companies Display Visible Joy as Traditional Chinese Medicine and Chronic Disease Drugs Take Center Stage
The annual national medical insurance catalog negotiations have once again entered the stage of on-site bargaining.
Day One of the 2026 National Reimbursement Drug List (NRDL) Negotiations: Corporate Representatives Barely Conceal Their Joy as Traditional Chinese Medicine and Chronic Disease Drugs Take Center Stage
① The first day of the 2026 national negotiations kicked off with traditional Chinese medicine (TCM) companies such as China Resources Sanjiu, Guangyuyuan, and Kangyuan Pharmaceutical taking the lead; ② In the afternoon session, Hengrui Pharma, Pfizer, and Novo-Nordisk A/S took over, initiating intensive negotiations for chronic disease medications; ③ The overall atmosphere was relatively relaxed, with corporate representatives barely concealing their satisfaction, as mechanisms like “pre-communication” have helped advance market access under the medical insurance scheme.
Cui Dongshu: Revenue of major domestic listed automakers reached RMB 1.293 trillion in the first half of the year, with growth slowing significantly.
In the first half of 2026, China's automotive industry is undergoing a profound transformation amid intense competition in the existing market. As the penetration rate of new energy vehicles continues to rise, the sector is characterized by a divergence where revenue growth does not translate into profit growth, creating a stark contrast between thriving and struggling segments.
The first Chinese humanoid robot ETF has been listed in the United States. What are the underlying reasons?
According to Defiance ETFs, the top ten constituents of CROB are exclusively leading companies in China’s industrial supply chain: Leader Harmonious Drive, Huichuan Technology, Lingyi iTech, Sanhua, Megmeet, Hengli Hydraulic, Tuopu Group, Luxshare Precision, CATL, and Wolong Electric Drive.
Xiao K Morning Brief | OpenAI Releases GPT-6, Touted as the "World's Most Intelligent" Large Language Model; Yangtze Memory Technologies' STAR Market IPO Under Regulatory Inquiry
① China's 2026 national medical insurance price negotiations are scheduled for September 5; ② OpenAI and Anthropic experienced service outages; ③ NVIDIA RTX Spark Windows PCs will launch in October 2026.
STAR Market Evening Brief | Jingzhida Signs RMB 1.576 Billion Procurement Agreement for Semiconductor Test Equipment; Enflame Technology Allotment Results Announced
1. Huafeng Technology plans to jointly invest with related parties to establish the Changhong Sci-Tech Innovation Fund; 2. Moore Threads has already onboarded key clients in critical sectors, including leading internet companies and telecommunications carriers, in the first half of the year; 3. Fuguang Shares and Dizal Pharma have disclosed share reduction plans; 4. Kejie Intelligence won the bid for an automated logistics warehousing project for a well-known cross-border e-commerce platform in Southeast Asia.
20,657 allocations! Winning lottery numbers for the leading AI chip maker announced | Post-market announcement roundup
JCET Group: Plans private placement to raise up to RMB 6.5 billion for capacity expansion of high-performance computing advanced packaging platform and other projects
FTSE Russell Rebalances China Core Index, Adding Several Leading STAR Market Semiconductor Companies
① FTSE Russell recently announced revisions to two of its indices, which will include several leading semiconductor companies from the Chinese mainland market, including AMEC, Shengyi Technology, Hua Hong Hongli, and Montage Technology; ② A review of recent index iteration trends shows that FTSE Russell has been continuously increasing the weight of hard-tech enterprises in its core indices, with hard-tech assets gradually becoming a core allocation theme recognized by foreign investors.
Optical network hardware vendors may emerge as the biggest winners in the AI era; institutions express optimism about a rebound in the optical communications sector.
① Deutsche Bank points out that hardware companies in the optical network business are poised to be the biggest winners in the AI era. ② A research report by Guolian Minsheng Securities indicates that following recent sector adjustments, market concerns over a slowdown in AI capital expenditure are expected to gradually ease, maintaining a positive outlook on the continued prosperity of the optical communication industry and a sector rebound.
Xiao K Morning Brief | Broadcom's Q3 FY2026 Revenue Surges 86% Year-on-Year; Enflame Technology Announces IPO Allotment Ratio
1. The FTSE China A50 Index includes Advanced Micro-Fabrication Equipment and Shengyi Technology; 2. Tight supply of Taiwan Semiconductor's CoWoS packaging has shifted customer focus to Intel's EMIB-T; 3. As of August 31, Zhang Jianping is no longer among the top ten shareholders of Zhongji Innolight.
0.0246%! Lottery rate for the third most expensive IPO of the year is announced | Post-market Announcement Roundup
As of August 31, Zhang Jianping has exited the list of the top ten shareholders of Zhongji Innolight. He was ranked as the ninth-largest shareholder at the end of the second quarter.
Interim dividend activity on the STAR Market heats up: 81 companies plan to distribute approximately RMB 6.7 billion in cash, with industry leaders topping the payout list.
① Under the combined influence of normalized regulatory guidance, the demonstrated resilience of listed companies' earnings, and sustained improvements in cash flow, enthusiasm for interim dividends in the A-share market continues to rise; ② A total of 81 companies listed on the STAR Market have announced their 2026 interim dividend plans, with a total dividend distribution amounting to approximately RMB 6.7 billion.